Leadership Overview
Bausch & Lomb has 10 executives leading key functions including strategy, finance, human resources, information technology, legal, consumer products, and research & development.
Driven by innovation, Bausch & Lomb is dedicated to advancing eye health through a comprehensive portfolio of products, fostering a culture of scientific excellence, and delivering impactful solutions to patients and consumers worldwide.
Driven by innovation, Bausch & Lomb is dedicated to advancing eye health through a comprehensive portfolio of products, fostering a culture of scientific excellence, and delivering impactful solutions to patients and consumers worldwide.
Leadership Roles at Bausch & Lomb
Brent Saunders - Chairman & Chief Executive Officer
Brent Saunders, the Chairman & Chief Executive Officer at Bausch & Lomb, directs the overarching corporate strategy and operational execution for the global eye health company. Saunders guides the development, manufacturing, and marketing of a diverse range of healthcare products, encompassing over-the-counter items, dietary supplements, eye care solutions, ophthalmic pharmaceuticals, contact lenses, and surgical devices. This leadership role involves setting the vision for market expansion and ensuring alignment with the company's mission to advance eye health. By overseeing all major business units, Brent Saunders drives innovation and operational efficiency across the organization, solidifying Bausch & Lomb's position in the competitive healthcare landscape. The Chairman & Chief Executive Officer's strategic decisions directly influence product development pipelines and market penetration strategies, ensuring sustained growth and a commitment to patient well-being.
Thomas Meier - Chief Financial Officer
Thomas Meier, the Chief Financial Officer at Bausch & Lomb, manages the company's financial operations and strategic fiscal planning. Meier oversees all aspects of financial reporting, budgeting, and capital allocation, ensuring the fiscal health and stability of the organization. This executive role involves close collaboration with other C-suite leaders to support business objectives through sound financial management. The Chief Financial Officer's responsibilities extend to optimizing financial performance and identifying opportunities for investment and cost efficiency across Bausch & Lomb's diverse product lines, including pharmaceuticals, contact lenses, and surgical instruments. By providing critical financial insights, Thomas Meier enables informed decision-making that supports the company's growth initiatives and its commitment to delivering high-quality eye health solutions globally.
Sam Eldessouky - Executive Vice President & Chief Financial Officer
Sam Eldessouky, the Executive Vice President & Chief Financial Officer at Bausch & Lomb, directs financial strategy and operational finance for the organization. Eldessouky's purview includes managing financial planning, analysis, and reporting to ensure robust fiscal management across Bausch & Lomb's extensive product portfolio, which spans over-the-counter items, dietary supplements, and advanced ophthalmic surgical devices. This critical role involves partnering with executive leadership to drive financial performance and support strategic growth initiatives. The Executive Vice President & Chief Financial Officer's expertise is vital in optimizing resource allocation and ensuring compliance with financial regulations. Through meticulous financial oversight, Sam Eldessouky underpins the company's ability to innovate and expand its reach in the global eye health market.
Pamela Boone - Executive Vice President & Chief Financial Officer
Pamela Boone, the Executive Vice President & Chief Financial Officer at Bausch & Lomb, oversees the company's financial architecture and strategic fiscal direction. Boone's responsibilities encompass managing financial reporting, budgeting processes, and investment strategies to support Bausch & Lomb's global operations in eye health. This executive leadership position requires close coordination with departmental heads to ensure financial objectives align with the company's mission of developing and marketing healthcare products. The Executive Vice President & Chief Financial Officer plays a key part in driving financial discipline and identifying opportunities for enhanced profitability across all business segments, from contact lenses to ophthalmic pharmaceuticals. Through expert financial stewardship, Pamela Boone ensures the sustained viability and growth of Bausch & Lomb's market presence.
Johnathan Ferris - President, Consumer
Johnathan Ferris, the President, Consumer at Bausch & Lomb, leads the strategic direction and operational execution for the company's consumer product division. Ferris oversees the development, marketing, and sales of a wide range of over-the-counter products and dietary supplements aimed at enhancing eye health. This executive role involves identifying market trends and consumer needs to drive product innovation and expand market share within the consumer healthcare segment. The President, Consumer works closely with cross-functional teams to ensure product quality and accessibility for customers globally. By focusing on consumer engagement and product efficacy, Johnathan Ferris significantly contributes to Bausch & Lomb's mission of providing accessible eye care solutions.
Kevin DeRyke - President, Viice Contact Lens Research & Development
Kevin DeRyke, the President, Viice Contact Lens Research & Development at Bausch & Lomb, spearheads innovation and product advancement in contact lens technology. DeRyke directs the research and development efforts focused on creating next-generation contact lenses that offer enhanced comfort, vision correction, and eye health benefits. This leadership position involves overseeing scientific exploration, clinical trials, and the translation of research findings into marketable products. The President, Viice Contact Lens Research & Development collaborates with manufacturing and marketing teams to ensure the successful launch and adoption of new contact lens solutions. Through dedicated scientific leadership, Kevin DeRyke drives Bausch & Lomb's commitment to pioneering advancements in vision care and meeting the evolving needs of contact lens wearers globally.
Asli Gevgilili - Executive Vice President & Chief Human Resources Officer
Asli Gevgilili, the Executive Vice President & Chief Human Resources Officer at Bausch & Lomb, leads all human capital strategies and organizational development initiatives. Gevgilili is responsible for cultivating a high-performance culture that supports the company's mission in eye health product development and manufacturing. This executive position involves overseeing talent acquisition, employee engagement, compensation and benefits, and leadership development programs across the global workforce. The Executive Vice President & Chief Human Resources Officer ensures that Bausch & Lomb attracts and retains top talent essential for innovation in areas like ophthalmic pharmaceuticals and contact lens technology. By fostering a supportive and dynamic work environment, Asli Gevgilili directly contributes to the company's operational excellence and its ability to meet the evolving needs of patients and consumers.
Peter Fourie - Senior VP, Chief Information Officer
Peter Fourie, the Senior VP, Chief Information Officer at Bausch & Lomb, leads the company's information technology strategy and infrastructure. Fourie is responsible for ensuring that technology systems effectively support Bausch & Lomb's global operations, including the development, manufacturing, and distribution of eye health products. This executive role involves overseeing cybersecurity, data management, and the implementation of digital solutions that enhance operational efficiency and innovation. The Chief Information Officer's strategic direction is crucial for maintaining the integrity of information systems that support everything from contact lens production to ophthalmic pharmaceutical research. By driving technological advancements, Peter Fourie enables Bausch & Lomb to maintain its competitive edge and deliver superior eye care solutions worldwide.
Robert Bailey - Chief Legal Officer
Robert Bailey, the Chief Legal Officer at Bausch & Lomb, directs all legal affairs and ensures corporate compliance across the organization. Bailey oversees the legal framework supporting Bausch & Lomb's global operations, including product development, manufacturing, and marketing of healthcare products. This executive position involves managing regulatory affairs, intellectual property, and litigation, safeguarding the company's interests. The Chief Legal Officer provides critical counsel on legal matters related to ophthalmic pharmaceuticals, contact lenses, and surgical devices, ensuring adherence to international standards. By maintaining a robust legal and compliance structure, Robert Bailey supports Bausch & Lomb's commitment to ethical business practices and its mission to advance eye health worldwide.
Doreen Richman - Senior Executive BP - Assisting the Offices of the Executive Vice President, Consumer and the Chief Communications Officer
Doreen Richman, the Senior Executive BP - Assisting the Offices of the Executive Vice President, Consumer and the Chief Communications Officer at Bausch & Lomb, provides critical support to key executive functions. Richman facilitates strategic initiatives within the consumer product division and aids in shaping the company's external communications. This role involves coordinating efforts to enhance brand messaging and ensure alignment between consumer product strategies and corporate communication objectives. The Senior Executive BP plays a vital part in operationalizing executive directives, ensuring smooth workflow and effective execution of plans related to Bausch & Lomb's market presence and product outreach. By bridging executive offices, Doreen Richman contributes to the cohesive advancement of the company's goals in eye health.
Explore Leadership Teams in Manufacturing
Siemens Healthineers, founded in 1847 and headquartered in Bavaria, Germany, is a global medical technology company specializing in manufacturing medical equipment and providing healthcare software solutions. The company offers a comprehensive portfolio of products and services in diagnostic imaging, laboratory diagnostics, and advanced therapies to help healthcare providers deliver high-quality patient care. Siemens Healthineers operates across multiple continents with a significant presence in Europe, North America, and Asia, serving hospitals, clinics, and medical facilities worldwide with innovative medical technology solutions.
Company Leadership DK
SZ
Cordis is a global medical-device company that specializes in interventional cardiovascular technologies. With more than 60 years of experience, it develops and manufactures minimally invasive devices such as guidewires, catheters, balloons, stents, and vascular closure systems to treat coronary and peripheral vascular diseases.
Company Leadership NP
AK
HD
Nipro Medical Corporation (http://www.nipro.com/), headquartered in Bridgewater, is a wholly-owned subsidiary of Nipro Corporation, headquartered in Osaka, Japan. Established in 1954, our parent company employs more than 29,000 team members and specializes in medical, pharmaceutical, and glass products. Nipro Corporation is the global leader in medical technology - alleviating pain, restoring health, and extending life for millions of people around the world.
Company Leadership MP
AC
MV
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.
Company Leadership DS
Frequently Asked Questions Regarding Bausch & Lomb Top Executives and Leadership Team
